Phosphodiesterase type-5 inhibitors and the reemerging HIV epidemic

JAMA

Volumn 299, Issue 12, 2008, Pages 1426-

  Hulgan, Todd ^a   Klausner, Jeffrey D ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; METHAMPHETAMINE; PHOSPHODIESTERASE V INHIBITOR; RECREATIONAL DRUG; SILDENAFIL; TADALAFIL; VARDENAFIL; PHOSPHODIESTERASE INHIBITOR; VASODILATOR AGENT;

EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; UNITED STATES; ADDICTION; HIGH RISK BEHAVIOR; HOMOSEXUALITY; NOTE;

HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; RISK-TAKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VASODILATOR AGENTS;

EID: 41149114574     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.12.1426     Document Type: Letter

References (5)

1. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA. 2007;298(20):2412-2414.
2. Sanchez TH, Gallagher KM. Factors associated with recent sildenafil (Viagra) use among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2006;42(1):95-100.
3. Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med. 2005;118(6):571-577.
4. Spindler HH, Scheer S, Chen SY, et al. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis. 2007; 34(8):586-591.
5. Rosen RC, Catania JA, Ehrhardt AA, et al. The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention. J Sex Med. 2006;3(6):960-975.